Clinical Breast Cancer

Published by: Elsevier Inc.  

People

  1. Hudis
    Hudis
  2. Seidman
    Seidman
  3. Patil
    Patil
  4. Norton
    Norton
  5. D'Andrea-Carlino
    D'Andrea-Carlino
  6. Dang
    Dang
  7. Modi
    Modi
  8. Fornier
    Fornier
  9. Lake
    Lake
  10. Sugarman
    Sugarman

Groups

  1. Solid Tumor Oncology Division (46)
  2. Breast Medicine Service (45)
  3. Survivorship Research (36)
  4. Breast Cancer Disease Management Team (26)
  5. Biostatistics Service (12)
  6. Epidemiology and Biostatistics (12)
  7. GSK Faculty (8)
  8. Radiology, Department of (7)
  9. Gynecologic Medicine Service (6)
  10. Body Imaging Service (5)
Search Within
Refine Results
Formats
  1. Journal Article (54)
  2. Review (1)
Groups
  1. Solid Tumor Oncology Division (46)
  2. Breast Medicine Service (45)
  3. Survivorship Research (36)
  4. Breast Cancer Disease Management Team (26)
  5. Biostatistics Service (12)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. Clifford Hudis (26)
  2. Andrew Seidman (19)
  3. Larry Norton (10)
  4. Sujata Patil (10)
  5. Gabriella D'Andrea-Carlino (8)
  6. Monica Fornier (8)

More People

Years
  1. 2020 (2)
  2. 2018 (5)
  3. 2017 (4)
  4. 2016 (4)
  5. 2014 (2)
  6. 2013 (3)

More Years

Publishers
  1. Elsevier Inc. (55)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Case-based review and clinical guidance on the use of genomic assays for early-stage breast cancer: Breast Cancer Therapy Expert Group (BCTEG)
    Review

    Kittaneh, M.; Badve, S.; Caldera, H.; Coleman, R.; Goetz, M. P.; Mahtani, R.; Mamounas, E.; Kalinsky, K.; Lower, E.; Pegram, M.; more...
    Clinical Breast Cancer (2020)

    Fulltext@MSK | Save
  • Incidence and management of diarrhea with adjuvant pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive breast cancer
    Journal Article

    Bines, J.; Procter, M.; Restuccia, E.; Viale, G.; Zardavas, D.; Suter, T.; Arahmani, A.; Van Dooren, V.; Baselga, J.; Clark, E.; more...
    Clinical Breast Cancer (2020)

    Fulltext@MSK | Save
  • Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer
    Journal Article

    Cadoo, K. A.; Kaufman, P. A.; Seidman, A. D.; Chang, C.; Xing, D.; Traina, T. A.
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of ixabepilone and capecitabine in patients with advanced triple-negative breast cancer: A pooled analysis from two large phase III, randomized clinical trials
    Journal Article

    Rugo, H. S.; Roche, H.; Thomas, E.; Chung, H. C.; Lerzo, G. L.; Vasyutin, I.; Patel, A.; Vahdat, L.
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II to III HER-2/neu-positive breast cancer: A retrospective, single institution experience
    Journal Article

    Murthy, R. K.; Raghavendra, A. S.; Hess, K. R.; Fujii, T.; Lim, B.; Barcenas, C. H.; Zhang, H.; Chavez-Mac-Gregor, M.; Mittendorf, E. A.; Litton, J. K.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection
    Journal Article

    Morikawa, A.; Wang, R.; Patil, S.; Diab, A.; Yang, J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • RESILIENCE: Phase III randomized, double-blind trial comparing sorafenib with capecitabine versus placebo with capecitabine in locally advanced or metastatic HER2-negative breast cancer
    Journal Article

    Baselga, J.; Zamagni, C.; Gómez, P.; Bermejo, B.; Nagai, S. E.; Melichar, B.; Chan, A.; Mángel, L.; Bergh, J.; Costa, F.; more...
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save
  • Family-building after breast cancer: Considering the effect on adherence to adjuvant endocrine therapy
    Journal Article

    Benedict, C.; Thom, B.; Teplinsky, E.; Carleton, J.; Kelvin, J. F.
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save
  • A rare case of S310F somatic ERBB2 mutation in a HER2-nonamplified breast cancer
    Journal Article

    Jasra, S.; Opyrchal, M.; Norton, L.; Mehta, R.
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save

    • Clinical Breast Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Clinical Breast Cancer 15268209 Unknown
    Clinical Breast Cancer 15268209 Elsevier Inc.
    Clinical Breast Cancer 15268209 The Authors
    Clinical Breast Cancer 1526-8209 Elsevier Inc.
    Clinical Breast Cancer 1526-8209 Elsevier Inc.
    Clinical Breast Cancer 19380666 2011
    Clinical Breast Cancer 1526-8209 Cig Media Group, Lp
    Clinical Breast Cancer 1526-8209 Unknown
    Clinical breast cancer 19380666 Unknown